.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

Blogs
Cancer Horizons
Clinical Trial Corner
CURE's 20th Anniversary Celebration
Publications
Recipes
Videos

Cancer TypeSee All >

Bladder
Breast
CLL
Kidney
Lung
MCL
Ovarian
Prostate
Skin

About CURE

Press Releases
Share Your Story
Write for CURE

About
Advertise / Support
Contact
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information

Winning the Carcinoid Battle

EP. 1: Larry Pleasant: Carcinoid Tumor Signs

October 27th 2017

EP. 2: Carcinoid Syndrome as a Chronic Disease

October 27th 2017

EP. 3: Understanding Carcinoid Tumor Behavior

October 27th 2017

EP. 4: Severe Diarrhea in Carcinoid Syndrome

October 27th 2017

EP. 5: Treatment for Neuroendocrine Tumors

October 27th 2017

EP. 6: Carcinoid Syndrome: Controlling Diarrhea

October 27th 2017

EP. 7: Maryann: From Patient to Advocate

October 27th 2017

EP. 8: Neuroendocrine Tumors: Hereditary Risk

October 27th 2017

EP. 9: Support and Resources for Patients

October 27th 2017

EP. 10: Neuroendocrine Tumors: Expert Care

October 27th 2017

EP. 11: Follow-Up Care for Neuroendocrine Tumors

October 27th 2017

EP. 12: Carcinoid Syndrome: Symptom Triggers

October 27th 2017

EP. 13: Awareness and Neuroendocrine Tumors

October 27th 2017

Latest News

First Patient Injected With Novel Radiotherapy in Phase 2b Trial for Brain Cancer

FDA Approves Orserdu for Some Patients with Metastatic Breast Cancer

FDA Approves Jaypirca for Relapsed/Refractory Mantle Cell Lymphoma

The Day I Realized My Oncologist Was a Real Person

View More Latest News